These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 4541038)
1. [Urinary hydroxyproline excretion in rheumatic conditions and under antirheumatic treatment]. Raab W Clin Chim Acta; 1973 Feb; 44(1):85-93. PubMed ID: 4541038 [No Abstract] [Full Text] [Related]
2. Urinary excretion of prolylhydroxyproline in rheumatic diseases. Bienenstock HKIBRICK AC Ann Rheum Dis; 1969 Jan; 28(1):28-30. PubMed ID: 5305862 [No Abstract] [Full Text] [Related]
3. Antirheumatic agents. Evens RP J Maine Med Assoc; 1979 Apr; 70(4):154-67. PubMed ID: 312309 [No Abstract] [Full Text] [Related]
4. Arthritis and rheumatism: old questions, new answers. Roth SH Compr Ther; 1984 Aug; 10(8):58-64. PubMed ID: 6331979 [No Abstract] [Full Text] [Related]
5. Symptomatic antirheumatic problems with the older patient: drug interactions. Miehlke K Rheumatol Rehabil; 1979; Suppl():104-8. PubMed ID: 312522 [No Abstract] [Full Text] [Related]
6. Influence of anti-rheumatic drugs on urinary excretion of hydroxyproline in lathyrism. Trnavská Z; Trnavský K Nature; 1967 Apr; 214(5086):384. PubMed ID: 6032834 [No Abstract] [Full Text] [Related]
7. [Study on the effect of antirheumatic therapy on the indices of the leukocyte migration inhibition test using myocardial cell membrane antigens in patients with rheumatism]. Borisova AM; Arion VIa; Petrov RV Ter Arkh; 1977; 49(11):40-5. PubMed ID: 305132 [No Abstract] [Full Text] [Related]
14. The development of an antirheumatic drug. Adams SS Rheumatol Phys Med; 1971 May; 11(2):89. PubMed ID: 5314254 [No Abstract] [Full Text] [Related]
15. Excretion of hydroxyproline in patients with rheumatic and non-rheumatic diseases. ZIFF M; KIBRICK A; DRESNER E; GRIBETZ HJ J Clin Invest; 1956 Jun; 35(6):579-87. PubMed ID: 13319493 [No Abstract] [Full Text] [Related]
16. [Drug therapy of rheumatic diseases]. Chlud K Med Welt; 1975 Nov; 26(45):2044-50. PubMed ID: 1105051 [No Abstract] [Full Text] [Related]
17. [Excretion of 5-HIAA in 24-hr urine of children affected with rheumatic diseases]. Szajner-Milart I Ann Univ Mariae Curie Sklodowska Med; 1968; 23():205-16. PubMed ID: 5311007 [No Abstract] [Full Text] [Related]
18. Hydroxyproline excretion in the urine as a measure of anti-inflammatory effect in rheumatic patients using naproxen. Tiselius P Scand J Rheumatol Suppl; 1973; 2():109-12. PubMed ID: 4590033 [No Abstract] [Full Text] [Related]
19. [Institute of Rheumatology and progress of antirheumatic therapy]. Sigidin IaA Vestn Ross Akad Med Nauk; 1998; (12):7-9. PubMed ID: 9987950 [TBL] [Abstract][Full Text] [Related]